Sale!

Saltra Inhaler HFA 25+125Mcg

617

Description

Saltra Inhaler HFA 25+125Mcg Precaution

Pulmonary tuberculosis, severe cardiovascular disorders, diabetes, hypokalaemia, thyrotoxicosis. Paradoxical bronchospasm; discontinue immediately. Prolonged treatment with high doses increases risk of adrenal suppression and systemic effects; monitor adrenal function. Monitor height of children on prolonged therapy. Consider additional steroid therapy during stress or surgery. Pregnancy, lactation. Withdraw gradually.

Indications

Regular treatment of asthma where long acting b2-agonist and inhaled corticosteroid is appropriate. Severe COPD. Dosage Adults: 2 inhalations twice daily at lowest effective inhaled corticosteroid dose. Children: under 4 yr, not recommended; over 4 yr, 2 inhalations of Salmicort 25/50 preparation twice daily.

Reviews

There are no reviews yet.

Be the first to review “Saltra Inhaler HFA 25+125Mcg”

Your email address will not be published.